Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy in terms of Progression-Free Survival (PFS) for each comparison of selumetinib in combination with docetaxel, compared to placebo in combination with docetaxel
Critère d'inclusion
- Locally Advanced or Metastatic Non Small Cell Lung Cancer stage IIIb - IV